Scandinavian Biopharma
Peter Liss is an experienced finance professional with a diverse background in leadership roles across various industries. Currently serving as CFO and Head of Business Development at Scandinavian Biopharma since February 2017, Peter previously held senior consultant positions at Peter Liss AB and executive roles at Valneva, where oversight included navigating ownership changes, and Anoto, focusing on financial recovery. Additional experience encompasses finance director roles at M&M Medical, consultancy at Apelsin Invest, and key leadership positions at Toolex and TV1000/Viasat. Peter began their career in finance at IBM, following an MBA from the Stockholm School of Economics.
This person is not in any teams
Scandinavian Biopharma
We are a research-based specialty biopharma company determined to give people all over the world a longer and better life. We are developing the first vaccine for protection against diarrhoea caused by ETEC in both travellers and endemic populations. We distribute a wide range of specialty biopharma products with focus on vaccines and immunoglobulins.